| Name: | Aegerion Pharmaceuticals, Inc. |
| Jurisdiction: | Rhode Island |
| Entity type: | Foreign Corporation |
| Status: | Activ |
| Date of Organization in Rhode Island: | 11 Jan 2017 (8 years ago) |
| Identification Number: | 001669912 |
| Place of Formation: | DELAWARE |
| Principal Address: | 160 FEDERAL STREET 21ST FLOOR, BOSTON, MA, 02110, USA |
| Purpose: | SALE OF PHARMACEUTICALS |
| NAICS: | 424210 - Drugs and Druggists' Sundries Merchant Wholesalers |
| Name | Role | Address |
|---|---|---|
| CORPORATION SERVICE COMPANY | Agent | 222 JEFFERSON BOULEVARD SUITE 200, WARWICK, RI, 02888, USA |
| Name | Role | Address |
|---|---|---|
| JON ZWINSKI | PRESIDENT | 21ST FLOOR 160 FEDERAL STREET BOSTON, MA 02110 USA |
| Name | Role | Address |
|---|---|---|
| MIKE GORDON | SECRETARY, TREASURER, DIRECTOR | 21ST FLOOR 160 FEDERAL STREET BOSTON, MA 02110 USA |
| Name | Role | Address |
|---|---|---|
| JOHN HESS | DIRECTOR | 21ST FLOOR 160 FEDERAL STREET BOSTON, MA 02110 USA |
| MATTEO CENI | DIRECTOR | 21ST FLOOR 160 FEDERAL STREET BOSTON, MA 02110 USA |
| DIEGO ARDIGO | DIRECTOR | 21ST FLOOR 160 FEDERAL STREET BOSTON, MA 02110 USA |
| Number | Name | File Date |
|---|---|---|
| 202452836660 | Annual Report | 2024-04-27 |
| 202334381390 | Annual Report | 2023-04-27 |
| 202218443460 | Annual Report | 2022-06-10 |
| 202193226920 | Annual Report | 2021-02-28 |
| 202034202670 | Annual Report | 2020-02-12 |
| 201924390950 | Miscellaneous Filing (No Fee) | 2019-10-03 |
| 201993865980 | Notice of Commencement of Bankruptcy | 2019-05-22 |
| 201987274600 | Annual Report | 2019-02-22 |
| 201855874820 | Annual Report | 2018-01-09 |
| 201729904730 | Application for Certificate of Authority | 2017-01-11 |
Date of last update: 26 Oct 2024
Sources: Rhode Island Department of State
